Lehigh Valley Health Network

LVHN Scholarly Works
USF-LVHN SELECT

A Clinical Guideline for the Endoscopic and Medical Management
in Children with Recurrent Croup
Harry Shi
Susan K. Yaeger MD
Sri Kiran Chennupati MD

Follow this and additional works at: https://scholarlyworks.lvhn.org/select-program
Part of the Medical Education Commons
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion
in LVHN Scholarly Works by an authorized administrator. For more information, please contact
LibraryServices@lvhn.org.

A Clinical Guideline for the Endoscopic and Medical Management in
Children with Recurrent Croup
Harry Shi, B.S., Susan K. Yaegar, M.D., Sri K. Chennupati, M.D.
Lehigh Valley Health Network, Allentown, Pennsylvania

Croup is a common respiratory condition seen in the pediatric population
that can occur in up to 15% of children typically between the ages of 6
months and 6 years old1. Croup has a 1.5 times higher incidence seen in
boys than girls, with peak incidence seen between 7 months to 36
months2,3. It is frequently caused by a viral infection and manifests as “seallike” barking cough and respiratory distress. Less commonly, roughly 5% but
as high as 6.4% of children experience recurrent coup which is defined as at
least 2 episodes of croup or croup-like symptoms4,1. Currently there is not a
strict guideline as to when endoscopic procedures like bronchoscopy and
laryngoscopy should be pursued in the setting of recurrent croup. Previous
studies have linked a history of asthma, gastroesophageal reflux disease
(GERD), and intubation among other risk factors in children to recurrent
croup and identified those risk factors as possible indications5,6. The
objectives of this project are to extend the current understanding of risk
factors for recurrent croup and to develop a medical treatment pathway
which will utilize risk factors as indicators for the use of endoscopic
procedures to identify underlying airway pathologies for recurrent croup in
the pediatric population at Lehigh Valley Health Network (LVHN).
The treatment for croup and recurrent croup has evolved over last few
decades. The primary management had once been the recommendation of
inhalation of humidified air8. Since then, multiple studies, including a
Cochrane Collaboration review, have shown that children with mild to
moderate croup did not improve with inhalation of humidified air9,10.
Currently, the use of corticosteroids, mainly the use of oral corticosteroids,
has become the new standard management of croup11. Other treatment
options include the use of racemic epinephrine and nebulized Lepinephrine7,11,12.

Problem Statement
Currently within the LVHN there is no established pathway indicating when
invasive procedures should be consulted in the management of recurrent
croup between the pediatricians, pediatric otolaryngologists (ENT), and family
medicine physicians. This study builds upon the work of JC Hiebert et al13. by
incorporating new study data published since their report and aims to use the
findings to build LVHN’s own clinical pathway for the management of croup
patients.

Figure 2 - History of intubation vs No intubation, outcome: Significant findings on bronchoscopy.

Figure 3 - History of Prematurity vs No prematurity, outcome: Significant findings on bronchoscopy.

Based on these new findings and recommendations from LVHN’s own pediatric emergency medicine
physician Dr. Susan Yaeger, a clinical management pathway for croup and recurrent croup is proposed
(Figure 9). Those patients who have the clinical diagnosis of croup should be assessed for severity
according to the Westley scoring system. Mild cases can be managed with outpatient treatment by
family medicine, pediatrics, and pediatric ENT, but these patients should be followed up regularly.
Those who are scored as moderate or severe croup should be advised to go to the Emergency
Department for further assessment. Standard treatment should be given to these patients, who should
be checked on once an hour for 2 hours. If patients’ symptoms have been clinically improved and meet
discharge criteria, they can be discharged and followed up as outpatients. If patients’ symptoms are
not improved and/or meet admission criteria, they should be hospitalized and receive 3 doses of
epinephrine treatment. If patients’ conditions are still not improved after treatment with 3 or more
doses of epinephrine, or if it is a case of recurrent croup, a pediatric ENT should be consulted. From
this point, the pediatric ENT physician can choose to proceed with invasive procedure or reassure the
parents depending on whether the patient has certain risk factors with significant associations with
endoscopic findings. This clinical pathway is proposed to assist in physician’s clinical decision making.
Each patient’s history is unique and then should be considered when making decisions on the best
management plan.
The data shows that 182 out of 1258 patients had significant findings on invasive diagnostic studies.
This means over 85% of patients underwent unnecessary invasive procedure. In order to better align
the current approach to recurrent croup to the SELECT teachings, this report by a multi-disciplinary
team of pediatric hospitalist, pediatric otolaryngologist, and pediatric emergency medicine physician
led by Dr. Chennupati aims to aid physicians in their decision-making process. With a focus on valuescentered patient care, by identifying significant patient risk factors, invasive diagnostic procedures can
become targeted towards patients with a higher chance of positive findings, thus sparring pediatric
patients from potential unnecessary iatrogenic trauma. By recommending a simple chart review on
pediatric recurrent croup patients to identify significant risk factors, the hope is for this process to
reduce the number of endoscopic procedures. In the long run, this will not only reduce general
healthcare cost for patients, but also improve the overall patient care experience for both the child and
their patients.
Croup Diagnosis/Severity Assessment

Outpatient/Primary
care setting

Moderate/Severe distress

Dexamethasone 0.150.6mg/kg15

Figure 4 - History of GERD vs No GERD, outcome: Significant findings on bronchoscopy.

ED for assessment and
workup
Stridor at rest AND one or
more:
intercostal/suprasternal
retractions; tachypnea;
agitation/restlessness/tired;
difficulty with talking or
feeding

No improvement

Follow up for dosage
and/or increased work of
breathing
Racemic Epinephrine 30
2.25% inhalation solution
(0.5 mL nebulized diluted
in 3mL NS)
+
Dexamethasone
0.6mg/kg
Discharge criteria with
outpatient ENT followup:
•Minimal stridor at rest
•Minimal retractions
•Able to talk or feed
•Has been 2 hours since
last dose of racemic epi

Figure 5 - History of Asthma/Allergy vs No Asthma/Allergy, outcome: Significant findings on bronchoscopy.

Observe for 2 hr, Q1 hour
assessment
(racepinephrine effect
lasts only 2 hrs)

Inpatient Admit criteria
•3 or more doses of racepinephrine
OR
•Continued stridor at rest
•Not meeting discharge criteria
•Consult ENT
(Recurrent croup with history of 2 or
more previous episodes should
also consult ENT)

Figure 6 - History of Inpatient Consult vs No Inpatient Consult, outcome: Significant findings on bronchoscopy.
Risk Factors for
Bronchoscopy/Endoscopy:
•History of prematurity
•History of previous
intubation
•Previous inpatient consult
•Age <1

No Risk Factors for
Bronchoscopy/Endoscopy:
•Reassure parents
•Continue treatment

Figure 9 – Outpatient dexamethasone dose based on
2011 review15. ED assessment based on 2007 study by
Bjornson and Johnson16.

Figure 7 - Age <1 vs Age >1, outcome: Significant findings on bronchoscopy.

This project was a designed quality improvement project by Dr. Sri Chennupati of the pediatric
ENT department. PubMed database searches were conducted using MeSH terms “recurrent croup”
AND “bronchoscopy” OR “endoscopy”. All prospective or retrospective studies on the pediatric
population published between 1990 and 2019 were included. Only fully accessibly publications were
included in this study. Recurrent croup was defined as two or more episodes of croup. A
bronchoscopic or endoscopic finding of significance was either deemed significant by the authors or
defined as grade II and great subglottic stenosis, requiring surgical intervention, or repeat
bronchoscopy for surveillance as established by Jabbour et al14. All relevant published studies were
checked for references and citations to ensure all notable studies were included. Any publications
that are case reports and/or of non-English language were excluded. The meta-analysis only included
studies in which patient risk factors were able to be linked to individual patients (Figure 1). Case
reports were excluded from the meta-analysis.
Review Manager 5.4 was used to determine the overall odds ratio and its 95% confidence interval
for each risk factor associated with recurrent croup. Sample data was added under dichotomous
data type. The inverse variance statistical method was used, with a fixed effect analysis model. Study
confidence intervals and total confidence intervals were set to 95%. The studies were sorted by year
of study on the forest plots.

The chance of any significant finding during an endoscopic exam for
recurrent croup is low. Most often, bronchoscopy or laryngoscopy is
performed just for the purpose to facilitate a parent’s ease of mind. There
should be a higher threshold before considering performing an invasive
procedure on a child. Those children with risk factors associated significant
endoscopic findings, such as a history prematurity, previous intubation,
inpatient consult for croup, and age <1, should be strong candidates for
endoscopic procedures. Physicians should utilize these indicators to assist in
their clinical decision making when selecting patients for bronchoscopy or
laryngoscopy.
An inherent weakness for this study is that all data were originated from
outside sources and may not accurately reflect the patient population seen
at LVHN. We hope to address this shortcoming with an internal chart review
of LVHN pediatric patients with croup and recurrent croup once there has
been IRB approval.

Figure 8 - Forest plot of comparison: Age <3 vs Age >3, outcome: Significant findings on bronchoscopy.

After going through the Pubmed data base using the search
parameters as described above, a total of 135 articles were found that
was published between 1990 and 2019. Articles were then screened
and only those that dealt with pediatric patient population with a
history of recurrent croup and have undergone bronchoscopy or
laryngoscopy were reviewed. Articles to which there was limited access
were excluded. One article published in Russian was excluded.
Meanwhile, the article on meta-analysis of croup published by JC
Hiebert et al.13 in 2016 was excluded as this study aims to update the
new findings since that publication.
A total of 15 articles was reviewed including 1258 pediatric patients
who were diagnosed with recurrent croup and underwent some sort of
invasive diagnostic study. Of those 1258 patients, 182 had shown
significant finding(s). Meta-analysis was done to study the association
between certain pre-procedural risk factors and significant intraprocedural findings. Our data showed that risk factors, including
previous intubation [OR = 5.47, 95% CI = 2.81-10.63], history of
prematurity [OR = 2.22, 95% CI = 1.26-3.91], history of inpatient consult
for croup [OR = 3.19, 95% CI = 1.65-6.19], and patient age <1 [OR = 2.92,
95% CI = 1.25-6.82], are associated with significant procedural findings.
A previous history of GERD [OR = 1.54, 95% CI = 0.97-2.45] and
Asthma/Allergies [OR = 0.90, 95% CI = 0.55-1.46] did not show
statistically significant association. In addition, patient age <3 [OR =
1.28, 95% CI = 0.77-2.14] also did not display statistically significant
association to procedural findings.
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